Project 3 >
Mutation Database >
MYBPC3 mutations >
IVS18+4A>T
(other names: Int18 DS A+4T)
SEQUENCE
| intron |
18 |
|---|
| nucleotide change | A>T |
| nucleotide pos. in
gene |
11075 |
| UCSC Golden Path position |
47320701 |
| charge change |
|
| codon change |
|
| transcript change |
splice site alteration |
| translation change |
|
mutated amplimer sequence:
ggaggagggggcgcaagtcaaatggtgagttccagaagcacggggcatgg
gtgttgggggcatctgcccagaagaggccacagcacttgccacccaccca
cccggctaggctgaaggacggggtggagctgacccgggaggagaccttca
aataccggttcaagaaggacgggcagagacaccacctgatcatcaacgag
gccatgctggaggacgcggggcactatgcactgtgcactagcgggggcca
ggcgctggctgagctcattgtgcagggtgTgcctggctgggggggcacat
gaggctttagggcttggacccctcagcccccaccccacctagccctgtag
gggagcaggcaaacctgggctcaaggcctctgtgaccttgggcctttgac
Date this novel mutation was originally posted on
this website: 6/9/2003
References and comments
- Fujino, Seidman et al., 2003. (this study)
- Ingles J, Doolan A, Chiu C, Seidman J, Seidman C, Semsarian C.
Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling.
J Med Genet. 2005 Oct;42(10):e59. (PubMed:16199542)
Clinical features of individuals in this study having
the MYBPC3:IVS18+4A>T mutation.
| pedigree |
sex |
height (in.) |
weight (lb.) |
age of onset |
age at exam |
NYHA Class |
LVWT, mm. |
LVED |
LVES |
LA |
EF, % |
diagnosis |
| FQ |
F |
64 |
146 |
|
34 |
|
26 |
43 |
23 |
38 |
55 |
HCM |
citations & disclaimer |
contact us
Last modified: April 24, 2006